Mesenchymal Stem Cell & Neurological Diseases

Mesenchymal stem cells are multipotent cells that are a readily available source of stem cells from bone marrow, adipose tissue, and umbilical cord blood. They have shown promise for therapeutic use in neurological diseases. Discover the latest research on mesenchymal stem cells and neurological diseases here.

September 18, 2021

Effect of tacrolimus on the expression of Park7 in glomerular podocytes injured by puromycin aminonucleoside.

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Jun-Jie TanLi Yu
September 14, 2021

Design, Synthesis, and Biological Evaluation of Hybrid Glypromate Analogues Using 2-Azanorbornane as a Prolyl and Pipecolyl Surrogate.

ACS Chemical Neuroscience
Ivo E Sampaio-DiasJosé E Rodríguez-Borges
September 14, 2021
Review
Open Access

Mesenchymal Stem Cell Therapy for Alzheimer's Disease.

Stem Cells International
A E Hernández, E García
September 10, 2021
Review
Open Access

The Role of Noncoding RNA in the Pathophysiology and Treatment of Premature Ovarian Insufficiency.

International Journal of Molecular Sciences
Katarzyna PankiewiczTadeusz Issat
September 6, 2021

Oxidative Stress Enhances Autophagy-Mediated Death Of Stem Cells Through Erk1/2 Signaling Pathway - Implications For Neurotransplantations.

Stem Cell Reviews and Reports
Ravi PrakashSyed Shadab Raza
September 6, 2021
Review

Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders.

Journal of Neurology
Hesham AbboudOn-behalf of the Guthy-Jackson Foundation NMO International Clinical Consortium
September 6, 2021

Inhibition of mitochondrial pyruvate carrier 1 by lapatinib ditosylate mitigates Alzheimer's-like disease in D-galactose/ovariectomized rats.

Neurochemistry International
Heba M MansourMahmoud M Khattab
August 28, 2021
Review
Open Access

Mesenchymal Stromal Cells Perspective: New Potential Therapeutic for the Treatment of Neurological Diseases.

Pharmaceutics
Takeo MukaiTokiko Nagamura-Inoue

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved
/feed-previews/mesenchymal-stem-cell-neurological/98a2666d-04a5-45d9-9c9c-26b9b7a3ce41